image
Fortress Biotech, Inc. FBIOP
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 5.1
0 %
$ 45.7 M
Market Cap
-5.91
P/E
BALANCE SHEET
168 M ASSETS
-43.08%
Growth Rates
1Year -43.08%
3Years -20.13%
5Years 3.51%
7Years -0.27%
10Years 5.23%
166 M LIABILITIES
-32.07%
Growth Rates
1Year -32.07%
3Years 7.97%
5Years 6.48%
7Years 9.53%
10Years 24.00%
22.5 M EQUITY
-45.96%
Growth Rates
1Year -45.96%
3Years -39.21%
5Years 64.85%
7Years -7.36%
10Years -12.04%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Fortress Biotech, Inc.
image
Current Assets 117 M
Cash & Short-Term Investments 80.9 M
Receivables 15.4 M
Other Current Assets 20.7 M
Non-Current Assets 50.5 M
Long-Term Investments 0
PP&E 23.5 M
Other Non-Current Assets 27 M
Current Liabilities 84.9 M
Accounts Payable 34.8 M
Short-Term Debt 9.45 M
Other Current Liabilities 40.6 M
Non-Current Liabilities 81 M
Long-Term Debt 79.1 M
Other Non-Current Liabilities 1.89 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 80.9 178.3 305.7 233.4 136.9 65.5 113.9 88.3 98.2 49.8 99.5 40.2 23.2
Short Term Investments 0 0 0 0 15.0 17.6 39.0 3.4 0 20.0 0 0 0
Receivables 15.4 28.3 23.8 19.3 14.4 7.6 8.4 8.7 0 0 0 0 0
Inventory 10.2 14.2 9.9 1.4 0.9 0.7 0.2 0.2 0 0 0 0 0
Other Current Assets 10.5 9.7 7.1 12.0 4.1 19.8 44.3 9.1 3.2 1.4 1.0 0.8 0.4
Total Current Assets 117.0 230.4 346.5 261.6 156.3 111.2 183.2 109.6 99.8 70.5 100.0 40.6 23.4
PP&E 23.5 33.0 34.1 32.4 33.9 12.0 9.5 7.4 0.3 52 K 0.4 51 K 0
Intangible Assets 20.3 27.2 12.6 14.6 7.4 1.4 15.2 17.4 1.2 0 0 0 0
Goodwill 0 0 0 0 0 0 18.6 18.6 0 0 0 0 0
Long Term Investments 0 2.7 2.2 17.6 11.1 16.1 1.4 1.4 2.5 4.2 0 0 0
Other Long Term Assets 6.7 3.7 3.4 2.7 17.7 16.4 18.0 16.3 14.8 14.7 0.1 0.3 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 167.5 294.3 396.5 328.8 226.4 141.0 245.9 170.7 118.6 89.3 100.6 41.0 23.4
LIABILITIES
Accounts Payable 34.8 57.2 47.4 11.4 35.5 17.9 10.0 14.2 1.9 0.4 0.5 1.0 0.6
Short Term Debt 9.5 12.6 7.4 6.4 10.8 19.1 13.2 2.0 0 0.2 6.2 1.8 0
Other Current Liabilities 39.8 56.4 43.2 33.8 (0.6) 18.7 48.2 40.3 8.7 3.5 4.3 2.3 2.9
Total Current Liabilities 84.9 127.7 101.0 48.0 45.6 55.6 67.4 56.6 10.6 4.1 11.2 5.1 3.5
Long Term Debt 79.1 114.7 67.6 82.7 106.1 60.4 49.3 26.2 23.2 14.3 7.4 12.8 0.8
Deferred Tax Income 0 0 0 0 0 0 0 0 (0.5) 0 0 0 0
Other Liabilities 1.9 1.8 2.0 1.9 2.1 5.2 4.7 5.0 0.6 0.5 0.7 1.0 0
Total Liabilities 165.9 244.3 170.6 131.8 153.9 121.2 125.4 87.8 34.3 18.8 19.3 19.0 4.2
EQUITY
Common Stock 15 K 0.1 0.1 95 K 0.6 0.7 0.6 49 K 47 K 46 K 40 K 24 K 19 K
Retained Earnings (694.9) (634.2) (547.5) (482.8) (436.2) (396.3) (312.1) (245.3) (190.2) (141.7) (121.3) (84.2) (56.6)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0.5 (2.6) (1.6) (0.5) 68 K 42 K 20 K 3 K (23.4)
Total Equity 1.6 50.0 225.9 197.0 72.5 19.7 120.5 83.0 84.3 70.5 81.3 22.0 19.1
Total Liabilities and Equity 167.5 294.3 396.5 328.8 226.4 141.0 245.9 170.7 118.6 89.3 100.6 41.0 23.4
SHARES OUTSTANDING
Common Shares Outstanding 8.1 5.9 5.4 4.8 3.6 2.9 2.8 2.7 2.6 2.4 2.0 1.4 7.7 5.9